Changing molecular epidemiology and resistance patterns of carbapenem-resistant Klebsiella pneumoniae in California long-term acute care hospitals

Clicks: 4
ID: 324284
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #251 of 427 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 427 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background The epidemiology of carbapenem-resistant Klebsiella pneumoniae (CRKP) must be monitored over time to understand resistance dynamics to existing and novel antibiotics. Methods Antibiotic susceptibility testing and whole-genome sequencing were performed on clinical CRKP isolates collected from the same California long-term acute care hospital network across two time periods: 2014-15 (period 1) and 2021-23 (period 2). Differences in sequence type (ST) diversity, carbapenem resistance-associated genotypes, and resistance to clinically important antibiotics were evaluated. Results Eight hundred eighty-one isolates were collected (period 1, 374; period 2, 507). Study period 1’s population was dominated by ST258 (94.1%). ST diversity markedly increased in period 2, with a reduced prevalence of ST258 (41.6%) and an increased abundance of other epidemic lineages: ST14 (27.4%), ST307 (6.9%), and ST17 (6.5%). Changes to circulating resistance genotypes and plasmids reflected the increased ST diversity. Increases in blaKPC-3-harboring isolates (66.0% vs. 76.1%) and non-carbapenemase-containing isolates (2.7% vs 12.6%) aligned with decreases in blaKPC-2-harboring isolates (30.5% vs. 6.3%). Statistically significant differences in resistance patterns were also observed between study periods, including colistin (35.0% vs. 20.2%), fosfomycin (27.0% vs. 13.4%), meropenem-vaborbactam (9.4% vs. 2.0%), and ceftazidime-avibactam (1.1% vs. 9.1%). Differential patterns of resistance emergence and spread across circulating STs largely drove resistance patterns in study period 2. Conclusions The comparison of clinical CRKP isolates collected from the same healthcare network and separated by nearly a decade revealed increasing ST diversity, mainly due to the introduction of numerous epidemic lineages, which coincided with differing patterns of circulating resistance-associated genotypes and antibiotic resistance.
Reference Key
openalex_W7201858209 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kyle J. Gontjes, Brendan J. Kelly, Leigh Cressman, Anne Jaskowiak-Barr, Laurel Glaser, Laura L Cowden, Alexa Patel, Jennifer Han, Ellie J C Goldstein, Warren B. Bilker, Evan S. Snitkin, Ebbing Lautenbach
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag406
URL
https://doi.org/10.1093/infdis/jiag406
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.